<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Market potential on FinanClub</title>
    <link>https://finan.club/tags/market-potential/</link>
    <description>Recent content in Market potential on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 19 Jan 2024 09:04:43 +0000</lastBuildDate><atom:link href="https://finan.club/tags/market-potential/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>QS</title>
      <link>https://finan.club/us/qs/</link>
      <pubDate>Fri, 19 Jan 2024 09:04:43 +0000</pubDate>
      
      <guid>https://finan.club/us/qs/</guid>
      <description>score:-8
Chances: Volkswagen&amp;rsquo;s interest in adapting the solid-state battery technology from France&amp;rsquo;s Blue Solutions could indicate potential for QuantumScape to also explore alternate partnerships and expand its reach in the industry. QuantumScape&amp;rsquo;s efforts to address customer hesitancy regarding EV batteries could position it to capitalize on the growing electric vehicle market.</description>
    </item>
    
    <item>
      <title>TGTX</title>
      <link>https://finan.club/us/tgtx/</link>
      <pubDate>Wed, 10 Jan 2024 09:03:07 +0000</pubDate>
      
      <guid>https://finan.club/us/tgtx/</guid>
      <description>score:343
Chances: TG Therapeutics, Inc. has entered into an agreement to acquire a worldwide license to Precision BioSciences, Inc.&amp;rsquo;s Azercabtagene Zapreleucel (azer-cel), an allogeneic CD19 CAR T cell therapy program for autoimmune diseases. The average of price targets set by Wall Street analysts indicates a potential upside of 127.</description>
    </item>
    
  </channel>
</rss>
